Therefore, we conclude that increased ERBB3 abundance and PIK3R1 expression and decreased ERBB2, FGFR3, and AKT2 expression may explain the improved LGG patient survival in IDH-mutant gliomas compared with IDH-wildtype gliomas. The gene discussed is ERBB2; the disease is glioma.